DYNE THERAPEUTICS ANNOUNCES ADDITIONAL ONE-YEAR CLINICAL DATA FROM PHASE 1/2 ACHIEVE TRIAL OF Z-BASIVARSEN (DYNE-101) FOR MYOTONIC DYSTROPHY TYPE 1 (DM1)

Reuters · 1d ago

Please log in to view news